Glioblastoma Standard of Care: Effects on Tumor Evolution and Reverse Translation in Preclinical Models.
Cancers (Basel).
2024 Jul 24;16(15). doi: 10.3390/cancers16152638. Review. PubMed PMID:
39123366; PubMed Central PMCID:
PMC11311277.
Optimization, Characterization, and Comparison of Two Luciferase-Expressing Mouse Glioblastoma Models.
Cancers (Basel).
2024 May 24;16(11). doi: 10.3390/cancers16111997. PubMed PMID:
38893116; PubMed Central PMCID:
PMC11171217.
Cognitive decline, Aβ pathology, and blood-brain barrier function in aged 5xFAD mice.
Fluids Barriers CNS.
2024 Mar 27;21(1):29. doi: 10.1186/s12987-024-00531-x. PubMed PMID:
38532486; PubMed Central PMCID:
PMC10967049.
A high-throughput single-cell RNA expression profiling method identifies human pericyte markers.
Neuropathol Appl Neurobiol.
2023 Dec;49(6):e12942. doi: 10.1111/nan.12942. PubMed PMID:
37812061; PubMed Central PMCID:
PMC10842535.
Proteasome inhibition protects blood-brain barrier P-glycoprotein and lowers Aβ brain levels in an Alzheimer's disease model.
Fluids Barriers CNS.
2023 Oct 6;20(1):70. doi: 10.1186/s12987-023-00470-z. PubMed PMID:
37803468; PubMed Central PMCID:
PMC10559617.
ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery.
Pharmacol Rev.
2023 Sep;75(5):815-853. doi: 10.1124/pharmrev.120.000025. Epub 2023 Mar 27. Review. PubMed PMID:
36973040; PubMed Central PMCID:
PMC10441638.
Characterization and comparison of human glioblastoma models.
BMC Cancer.
2022 Aug 3;22(1):844. doi: 10.1186/s12885-022-09910-9. PubMed PMID:
35922758; PubMed Central PMCID:
PMC9347152.
Apolipoprotein E genotype-dependent nutrigenetic effects to prebiotic inulin for modulating systemic metabolism and neuroprotection in mice via gut-brain axis.
Nutr Neurosci.
2022 Aug;25(8):1669-1679. doi: 10.1080/1028415X.2021.1889452. Epub 2021 Mar 5. PubMed PMID:
33666538; PubMed Central PMCID:
PMC8799401.
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.
Pharmacol Ther.
2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30. Review. PubMed PMID:
35108575; PubMed Central PMCID:
PMC9107516.
Brain barriers virtual: an interim solution or future opportunity?.
Fluids Barriers CNS.
2022 Mar 1;19(1):19. doi: 10.1186/s12987-022-00314-2. PubMed PMID:
35232464; PubMed Central PMCID:
PMC8886561.
Freshly isolated retinal capillaries to determine efflux transporter function at the inner BRB.
J Control Release.
2022 Mar;343:434-442. doi: 10.1016/j.jconrel.2022.01.037. Epub 2022 Jan 29. PubMed PMID:
35104569.
Drug Delivery to Primary and Metastatic Brain Tumors: Challenges and Opportunities.
In:
Drug Delivery to the Brain
[Internet]
AAPS Advances in the Pharmaceutical Sciences Series: Springer; 2022. p.723–762.
Available from: https://doi.org/10.1007/978-3-030-88773-5_24.
Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model.
Fluids Barriers CNS.
2021 Mar 6;18(1):10. doi: 10.1186/s12987-021-00245-4. PubMed PMID:
33676539; PubMed Central PMCID:
PMC7937299.
Participation of Monocarboxylate Transporter 8, But Not P-Glycoprotein, in Carrier-Mediated Cerebral Elimination of Phenytoin across the Blood-Brain Barrier.
Pharm Res.
2021 Jan;38(1):113-125. doi: 10.1007/s11095-021-03003-1. Epub 2021 Feb 1. PubMed PMID:
33527223; PubMed Central PMCID:
PMC8906351.
David S. Miller: Scientist, Mentor, Friend-a tribute and thank you.
Fluids Barriers CNS.
2020 Sep 14;17(1):56. doi: 10.1186/s12987-020-00220-5. PubMed PMID:
32928243; PubMed Central PMCID:
PMC7491162.
Cytosolic phospholipase A2 is a key regulator of blood-brain barrier function in epilepsy.
FASEB J.
2019 Dec;33(12):14281-14295. doi: 10.1096/fj.201901369RR. Epub 2019 Oct 29. PubMed PMID:
31661303; PubMed Central PMCID:
PMC6894050.
Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier.
FASEB J.
2019 Dec;33(12):13966-13981. doi: 10.1096/fj.201901460RR. Epub 2019 Oct 22. PubMed PMID:
31638830; PubMed Central PMCID:
PMC6894061.
Isolation of Cerebral Capillaries from Fresh Human Brain Tissue.
J Vis Exp.
2018 Sep 12;(139). doi: 10.3791/57346. PubMed PMID:
30272660; PubMed Central PMCID:
PMC6235165.
Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease.
Front Aging Neurosci.
2018;10:225. doi: 10.3389/fnagi.2018.00225. eCollection 2018. Review. PubMed PMID:
30140223; PubMed Central PMCID:
PMC6094969.
Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer's Disease Mouse Model.
Front Aging Neurosci.
2018;10:186. doi: 10.3389/fnagi.2018.00186. eCollection 2018. PubMed PMID:
29997495; PubMed Central PMCID:
PMC6028735.
Role of l-Type Amino Acid Transporter 1 at the Inner Blood-Retinal Barrier in the Blood-to-Retina Transport of Gabapentin.
Mol Pharm.
2018 Jun 4;15(6):2327-2337. doi: 10.1021/acs.molpharmaceut.8b00179. Epub 2018 May 2. PubMed PMID:
29688723.
Matrix Metalloproteinase-Mediated Blood-Brain Barrier Dysfunction in Epilepsy.
J Neurosci.
2018 May 2;38(18):4301-4315. doi: 10.1523/JNEUROSCI.2751-17.2018. Epub 2018 Apr 9. PubMed PMID:
29632167; PubMed Central PMCID:
PMC5932641.
Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice.
Sci Rep.
2018 Apr 27;8(1):6670. doi: 10.1038/s41598-018-25190-5. PubMed PMID:
29703936; PubMed Central PMCID:
PMC5923270.
Age Drives Distortion of Brain Metabolic, Vascular and Cognitive Functions, and the Gut Microbiome.
Front Aging Neurosci.
2017;9:298. doi: 10.3389/fnagi.2017.00298. eCollection 2017. PubMed PMID:
28993728; PubMed Central PMCID:
PMC5622159.
Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.
Front Neurol.
2017;8:301. doi: 10.3389/fneur.2017.00301. eCollection 2017. Review. PubMed PMID:
28729850; PubMed Central PMCID:
PMC5498483.
P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human Epilepsy.
Mol Pharm.
2017 Apr 3;14(4):999-1011. doi: 10.1021/acs.molpharmaceut.6b00770. Epub 2017 Mar 2. PubMed PMID:
28195743; PubMed Central PMCID:
PMC5498434.
Hitting the BBB: Technological advancements in CNS research and drug targeting.
The AAPS journal. 2017 April; :14-18.
Caloric restriction preserves memory and reduces anxiety of aging mice with early enhancement of neurovascular functions.
Aging (Albany NY).
2016 Nov 8;8(11):2814-2826. doi: 10.18632/aging.101094. PubMed PMID:
27829242; PubMed Central PMCID:
PMC5191872.
Highlights From the American Association of Pharmaceutical Scientists/ International Transporter Consortium Joint Workshop on Drug Transporters in Absorption, Distribution, Metabolism, and Excretion: From the Bench to the Bedside - Clinical Pharmacology Considerations.
Clin Pharmacol Ther.
2016 Nov;100(5):419-422. doi: 10.1002/cpt.439. Epub 2016 Sep 13. PubMed PMID:
27500791; PubMed Central PMCID:
PMC5466066.
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.
J Cereb Blood Flow Metab.
2016 Sep;36(9):1481-507. doi: 10.1177/0271678X16655551. Epub 2016 Jun 20. Review. PubMed PMID:
27323783; PubMed Central PMCID:
PMC5012524.
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.
J Neurosci.
2016 Feb 10;36(6):1930-41. doi: 10.1523/JNEUROSCI.0350-15.2016. PubMed PMID:
26865616; PubMed Central PMCID:
PMC4748076.
A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice.
PLoS One.
2016;11(1):e0147733. doi: 10.1371/journal.pone.0147733. eCollection 2016. PubMed PMID:
26808326; PubMed Central PMCID:
PMC4726499.
The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1.
Mol Membr Biol.
2015;32(2):39-45. doi: 10.3109/09687688.2015.1023378. Epub 2015 May 26. PubMed PMID:
26006083; PubMed Central PMCID:
PMC4844833.
ABC Transporters and the Alzheimer's Disease Enigma.
Front Psychiatry.
2012;3:54. doi: 10.3389/fpsyt.2012.00054. eCollection 2012. PubMed PMID:
22675311; PubMed Central PMCID:
PMC3366330.
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
Stroke.
2012 Feb;43(2):514-23. doi: 10.1161/STROKEAHA.111.627562. Epub 2011 Nov 23. PubMed PMID:
22116809; PubMed Central PMCID:
PMC5761312.
Aryl hydrocarbon receptor-dependent upregulation of Cyp1b1 by TCDD and diesel exhaust particles in rat brain microvessels.
Fluids Barriers CNS.
2011 Aug 25;8:23. doi: 10.1186/2045-8118-8-23. PubMed PMID:
21867498; PubMed Central PMCID:
PMC3180256.
Synthesis and characterization of a BODIPY conjugate of the BCR-ABL kinase inhibitor Tasigna (nilotinib): evidence for transport of Tasigna and its fluorescent derivative by ABC drug transporters.
Mol Pharm.
2011 Aug 1;8(4):1292-302. doi: 10.1021/mp2001022. Epub 2011 Jun 16. PubMed PMID:
21630681; PubMed Central PMCID:
PMC3148428.
ABC transporters in the CNS - an inventory.
Curr Pharm Biotechnol.
2011 Apr;12(4):656-73. doi: 10.2174/138920111795164020. Review. PubMed PMID:
21118088.
Engaging neuroscience to advance translational research in brain barrier biology.
Nat Rev Neurosci.
2011 Mar;12(3):169-82. doi: 10.1038/nrn2995. Review. PubMed PMID:
21331083; PubMed Central PMCID:
PMC3335275.
The blood-brain barrier in epilepsy.
In:
Afawi Z, editor.
Clinical and Genetic Aspects of Epilepsy
United States: InTech; 2011. Chapter 2; p.23-54. 23-54p.
Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up.
Curr Pharm Des.
2011;17(26):2793-802. doi: 10.2174/138161211797440186. Review. PubMed PMID:
21827403; PubMed Central PMCID:
PMC3269897.
17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.
J Cereb Blood Flow Metab.
2010 Oct;30(10):1742-55. doi: 10.1038/jcbfm.2010.36. Epub 2010 Mar 10. PubMed PMID:
20216549; PubMed Central PMCID:
PMC3023406.
Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy.
Mol Interv.
2010 Oct;10(5):293-304. doi: 10.1124/mi.10.5.6. Review. PubMed PMID:
21045243.
Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
J Pharmacol Exp Ther.
2010 Aug;334(2):467-76. doi: 10.1124/jpet.110.168930. Epub 2010 May 11. PubMed PMID:
20460386; PubMed Central PMCID:
PMC2913769.
Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
Mol Pharmacol.
2010 May;77(5):715-23. doi: 10.1124/mol.109.061754. Epub 2010 Jan 25. PubMed PMID:
20101004; PubMed Central PMCID:
PMC2872973.
Targeting regulation of ABC transporters at the blood-brain barrier to improve pharmacotherapy of CNS disorders.
International drug discovery. 2010; (August/September):76-79.
Novel and emerging strategies in drug delivery for overcoming the blood-brain barrier.
Future Med Chem.
2009 Dec;1(9):1623-41. doi: 10.4155/fmc.09.137. Review. PubMed PMID:
21425983.
Signaling to P-glycoprotein-A new therapeutic target to treat drug-resistant epilepsy?.
Drug News Perspect.
2009 Sep;22(7):393-7. doi: 10.1358/dnp.2009.22.7.1401354. Review. PubMed PMID:
19890496.
Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation.
J Pharmacol Exp Ther.
2009 Sep;330(3):939-47. doi: 10.1124/jpet.109.152520. Epub 2009 Jun 3. PubMed PMID:
19494186.
Pregnane X receptor (PXR) regulates P-glycoprotein at the blood-brain barrier: functional similarities between pig and human PXR.
J Pharmacol Exp Ther.
2009 Apr;329(1):141-9. doi: 10.1124/jpet.108.149690. Epub 2009 Jan 15. PubMed PMID:
19147857.
What would you like to do?